Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07290426) titled 'Vbeam Pro Pulse Dye Laser for the Treatment of Vascular Conditions' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Candela Corporation
Condition:
Rosacea
Vascular Diseases
Port-Wine Stain
Intervention:
Device: Vbeam Pro Laser Treatment
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 2026
Target Sample Size: 40
To know more, visit https://clinicaltrials.gov/study/NCT07290426
Disclaimer: Curated by HT Syndication....